Simon Cleary
@simoncleary.bsky.social
Research group leader and lecturer in pharmacology at King's College London: kcl.ac.uk/people/simon-cleary
Research interests: pulmonary vascular biology, immunology + developing new therapeutics and microscopy methods.
Research interests: pulmonary vascular biology, immunology + developing new therapeutics and microscopy methods.
Interested in new ways to study interactions between cancers and the immune system? If yes, have a read of this article on mine and Longhui Qiu's recent work, featured in Nature Reviews Cancer's Tools of the Trade series: rdcu.be/er3Iq
June 23, 2025 at 9:52 AM
Interested in new ways to study interactions between cancers and the immune system? If yes, have a read of this article on mine and Longhui Qiu's recent work, featured in Nature Reviews Cancer's Tools of the Trade series: rdcu.be/er3Iq
Congrats to Farsh Moussavi-Harami for discovering that deficiencies in SHP-1 (Ptpn6) lead to vasculitis and inflammatory bleeding in lung infections, and that increasing SHP-1 activity might be a useful way to suppress harmful neutrophil responses!
January 9, 2025 at 7:54 PM
Congrats to Farsh Moussavi-Harami for discovering that deficiencies in SHP-1 (Ptpn6) lead to vasculitis and inflammatory bleeding in lung infections, and that increasing SHP-1 activity might be a useful way to suppress harmful neutrophil responses!